Serum levels of fibroblast growth factor-21 are increased in chronic and acute renal dysfunction

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

An FGF21-Adiponectin-Ceramide Axis Controls Energy Expenditure and Insulin Action in Mice

(2013) William L. Holland et al.   Cell Metabolism

Serum levels of the adipokine fibroblast growth factor-21 are increased in preeclampsia

(2013) Holger Stepan et al.   CYTOKINE

Response to Comment on: Richter et al. Serum Levels of the Adipokine Progranulin Depend on Renal Function. Diabetes Care 2013;36:410-414

(2013) J. Richter et al.   DIABETES CARE

Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status

(2012) Yenna Lee et al.   CLINICAL ENDOCRINOLOGY

Serum Levels of the Adipokine Progranulin Depend on Renal Function

(2012) J. Richter et al.   DIABETES CARE

Fibroblast Growth Factor-21 (FGF21) Regulates Low-density Lipoprotein Receptor (LDLR) Levels in Cells via the E3-ubiquitin Ligase Mylip/Idol and the Canopy2 (Cnpy2)/Mylip-interacting Saposin-like Protein (Msap)

(2012) Hai Thi Do et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Circadian Rhythm of Circulating Fibroblast Growth Factor 21 Is Related to Diurnal Changes in Fatty Acids in Humans

(2011) H. Yu et al.   CLINICAL CHEMISTRY

High Plasma Level of Fibroblast Growth Factor 21 Is an Independent Predictor of Type 2 Diabetes: A 5.4-year population-based prospective study in Chinese subjects

(2011) C. Chen et al.   DIABETES CARE

Serum FGF21 levels are increased in newly diagnosed type 2 diabetes with nonalcoholic fatty liver disease and associated with hsCRP levels independently

(2011) Xuesong Li et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Circulating FGF21 Levels Are Progressively Increased from the Early to End Stages of Chronic Kidney Diseases and Are Associated with Renal Function in Chinese

(2011) Zhuofeng Lin et al.   PLoS One

Fibroblast Growth Factor 21 Action in the Brain Increases Energy Expenditure and Insulin Sensitivity in Obese Rats

(2010) D. A. Sarruf et al.   DIABETES

Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State

(2010) f. M. Fisher et al.   DIABETES

Serum fibroblast growth factor–21 concentration is associated with residual renal function and insulin resistance in end-stage renal disease patients receiving long-term peritoneal dialysis

(2010) Seung Hyeok Han et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Serum Levels of FGF-21 Are Increased in Coronary Heart Disease Patients and Are Independently Associated with Adverse Lipid Profile

(2010) Zhuofeng Lin et al.   PLoS One

Circulating Fibroblast Growth Factor-21 Is Elevated in Impaired Glucose Tolerance and Type 2 Diabetes and Correlates With Muscle and Hepatic Insulin Resistance

(2009) A. O. Chavez et al.   DIABETES CARE

Adiponectin Levels and Risk of Type 2 Diabetes

(2009) Shanshan Li et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Serum fibroblast growth factor 21 levels in gestational diabetes mellitus in relation to insulin resistance and dyslipidemia

(2009) Sebastian Stein et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Adiponectin and inducible ischemia in patients with stable coronary heart disease: data from the Heart and Soul study

(2008) Mary H. Zhang et al.   ATHEROSCLEROSIS

Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans

(2008) X. Zhang et al.   DIABETES

Serum Levels of the Adipokine FGF21 Depend on Renal Function

(2008) S. Stein et al.   DIABETES CARE

Fibroblast Growth Factor 21 Corrects Obesity in Mice

(2008) Tamer Coskun et al.   ENDOCRINOLOGY

Adipose tissue dysfunction in obesity, diabetes, and vascular diseases

(2008) G. R. Hajer et al.   EUROPEAN HEART JOURNAL